TY  - GEN
AU  - Buzdar,A U
AU  - Singletary,S E
AU  - Theriault,R L
AU  - Booser,D J
AU  - Valero,V
AU  - Ibrahim,N
AU  - Smith,T L
AU  - Asmar,L
AU  - Frye,D
AU  - Manuel,N
AU  - Kau,S W
AU  - McNeese,M
AU  - Strom,E
AU  - Hunt,K
AU  - Ames,F
AU  - Hortobagyi,G N
TI  - Prospective evaluation of paclitaxel versus combination chemotherapy with fluorouracil, doxorubicin, and cyclophosphamide as neoadjuvant therapy in patients with operable breast cancer
SN  - 0732-183X
PY  - 2000///0118
KW  - Adult
KW  - Aged
KW  - Antineoplastic Agents, Phytogenic
KW  - administration & dosage
KW  - Antineoplastic Combined Chemotherapy Protocols
KW  - adverse effects
KW  - Breast Neoplasms
KW  - drug therapy
KW  - Chemotherapy, Adjuvant
KW  - Cyclophosphamide
KW  - Doxorubicin
KW  - Female
KW  - Fluorouracil
KW  - Humans
KW  - Middle Aged
KW  - Neutropenia
KW  - chemically induced
KW  - Paclitaxel
KW  - Prospective Studies
N1  - Publication Type: Clinical Trial; Comparative Study; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
UR  - https://doi.org/10.1200/JCO.1999.17.11.3412
ER  -